Steroid-Refractory Chronic Graft-Versus-Host Disease: Treatment Options and Nursing Care

被引:0
|
作者
Cazeau, Naomi [1 ]
Rodriguez, Stephany [2 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA
[2] Univ Calif San Francisco, Dept Hematol Blood & Marrow Transplant & Cellular, San Francisco, CA USA
基金
美国国家卫生研究院;
关键词
stem cell transplantation; graft-versus-host disease; steroid-refractory GVHD; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; CRITERIA; TRANSPLANTATION; FAILURE;
D O I
10.1188/23.CJON.259-265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Chronic graft-versus-host disease (cGVHD) is a significant complication for patients who receive allogeneic hematopoietic stem cell transplantation. This disease is further complicated for patients who are refractory to steroids. This article reviews emerging therapies and supportive care for patients with steroid-refractory cGVHD.OBJECTIVES:This article provides foundational knowledge on steroid-refractory cGVHD, emerg-ing treatment options, and related supportive care.METHODS: Current research on emerging therapies for patients with steroid-refractory cGVHD is summarized along with supportive care recommendations and a review of related nursing considerations.FINDINGS: Emerging therapies for steroid -refractory cGVHD offer opportunities for improved clinical outcomes for these patients. Nursing knowledge of new therapies and supportive care for patients with steroid-refractory cGVHD supports the provision of optimal nursing care for a complex population of patients.
引用
收藏
页码:259 / 265
页数:7
相关论文
共 50 条
  • [1] Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
    Wolff, Daniel
    Fatobene, Giancarlo
    Rocha, Vanderson
    Kroeger, Nicolaus
    Flowers, Mary E.
    BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2079 - 2087
  • [2] Treatment and Nursing for Steroid-Refractory Acute Graft-Versus-Host Disease
    Cazeau, Naomi
    Rodriguez, Stephany L.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2023, 27 (04) : 397 - 403
  • [3] Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center
    Ferreira, Aliana Meneses
    Pontes da Silva, Carolina Atallah
    Pereira, Andre Domingues
    Szor, Roberta Shcolnik
    Brito Medeiros da Fonseca, Ana Rita
    Serpa, Mariana Gomes
    Xavier, Erick Menezes
    Sampaio de Melo, Michelly Kerly
    Novis, Yana
    Tucunduva, Luciana
    Rocha, Vanderson
    Arrais-Rodrigues, Celso
    BONE MARROW TRANSPLANTATION, 2018, 53 (04) : 503 - 506
  • [4] Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
    Wang, Dong
    Liu, Yin
    Lai, Xiaoxuan
    Chen, Jia
    Cheng, Qiao
    Ma, Xiao
    Lin, Zhihong
    Wu, Depei
    Xu, Yang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [5] Long-Term Follow-Up of Ruxolitinib in the Treatment of Steroid-Refractory Chronic Graft-versus-Host Disease
    Ferreira, Aliana Meneses
    Szor, Roberta Shcolnik
    Molla, Vinicius Campos
    Seiwald, Maria Cristina
    de Moraes, Pedro Arruda
    Brito Medeiros da Fonseca, Ana Rita
    Xavier, Erick Menezes
    Serpa, Mariana Gomes
    Tucunduva, Luciana
    Novis, Yana
    Arrais-Rodrigues, Celso
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (09): : 777.e1 - 777.e6
  • [6] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
  • [7] Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
    Chin, Kuo-Kai
    Kim, Haesook T.
    Inyang, Eno-Abasi
    Ho, Vincent
    Koreth, John
    Romee, Rizwan
    Gooptu, Mahasweta
    Shapiro, Roman
    Antin, Joseph
    Soiffer, Robert
    Jaglowski, Samantha
    Pidala, Joseph
    Cutler, Corey
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (12): : 990.e1 - 990.e7
  • [8] Extracorporeal photopheresis in steroid-refractory chronic graft-versus-host disease: A retrospective multicenter study
    Dal Sinan, Mehmet
    Batgi, Hikmettullah
    Erkurt, Mehmet Ali
    Hindilerden, Ipek Yonal
    Kuku, Irfan
    Kurtoglu, Erdal
    Kaya, Emin
    Besisik, Sevgi Kalayoglu
    Berber, Ilhami
    Nalcaci, Meliha
    Ulas, Turgay
    Altuntas, Fevzi
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (05)
  • [9] Sirolimus for treatment of steroid-refractory acute graft-versus-host disease
    Hoda, D.
    Pidala, J.
    Salgado-Vila, N.
    Kim, J.
    Perkins, J.
    Bookout, R.
    Field, T.
    Perez, L.
    Ayala, E.
    Ochoa-Bayona, J. L.
    Raychaudhuri, J.
    Alsina, M.
    Greene, J.
    Janssen, W.
    Fernandez, H. F.
    Anasetti, C.
    Kharfan-Dabaja, M. A.
    BONE MARROW TRANSPLANTATION, 2010, 45 (08) : 1347 - 1351
  • [10] A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host disease
    Fatoum, Hanaa
    Zeiser, Robert
    Hashmi, Shahrukh K.
    BLOOD REVIEWS, 2024, 63